Treprilimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Treprilimab, covering 2020-09-01 to 2020-09-01. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Clinical Study of Treprilimab in the Treatment of Recurrent Nasopharyngeal Carcinoma After Re-irradiation [Phase 2]